Closed Health
B-SMART

Brain-Specific, Modular and Active RNA Therapeutics

€5.9MFunding
66Months
9Partners

Fact sheet

Programme
Horizon 2020 & sub-programmes
Companies
EURICE
Duration
66 months (January 2017 – June 2022)
Project funding
€ 5,998,303.75
Project partners
9
Technology readiness level
4-7
Project website
http://b-smart-project.eu

About the project

B-SMART aims at designing and manufacturing modular nanoparticles via a quality-by-design protocol. These nanoparticles shall serve to deliver therapeutic RNAs to the brain and treat neurodegenerative diseases. B-SMART expects to arrive at a scale-able nanoparticle formulation with uniform characteristics that shows a strong pre-clinical evidence of therapeutic efficacy and is ready for clinical translation.

Coordinator

Prof. Raymond Schiffelers
Universitair Medisch Centrum Utrecht
Phone: +31 (0)637610587
Email coordinator